Bristol Myers Squibb BMY
NYSE BMY
$62.93 -0.50 (-0.79%)
At close: Nov 16, 2026 · 4:00 PM EST

Bristol Myers Squibb (BMY) EBITDA (2009 - 2026)

Updated

Bristol Myers Squibb's EBITDA came in at $3.16 billion for Q3 2026, down 23.3% from $4.13 billion a year earlier and down 32.4% from the prior quarter.

Analysis

Bristol Myers Squibb (BMY) EBITDA (2009 - 2026) Analysis & Trends

Over the trailing twelve months to Sep 30, 2026, Bristol Myers Squibb reported EBITDA of $14.12 billion, up 9.1% year-over-year; for FY2025, it came in at $13.34 billion, up 992.5% from FY2024.

  • EBITDA carries a five-year compound annual growth rate of 30.6% (FY2020 to FY2025).
  • Going back by year, EBITDA was $1.22 billion in FY2024 (-93.3%), $18.2 billion in FY2023 (+1.2%), $17.99 billion in FY2022 (-4.2%) and $18.78 billion in FY2021 (+435.3%).
  • The five-year range for quarterly EBITDA is -$8.98 billion (Q1 2024) to $5.2 billion (Q1 2023).
  • Year-over-year, EBITDA increased in two of the last seven quarters, with an average decline of 3.1%.
  • The fastest year-over-year change in EBITDA over five years came in Q2 2026 (growth of 68.1%), and the weakest in Q4 2024 (a decline of 50.3%).
  • Business Quant data shows BMY's EBITDA at $4.68 billion (Q2 2026), $3.83 billion (Q1 2026) and $2.45 billion (Q4 2025) in the three quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 8.95 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 8.30 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 8.16 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 7.34 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 5.99 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 4.83 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 4.20 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 7.05 Bn
10 Bristol Myers Squibb 128.63 Bn 83.82 Bn 8.92 Bn 3.16 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 3.16 Bn
Jun 30, 2026 4.68 Bn
Mar 31, 2026 3.83 Bn
Dec 31, 2025 2.45 Bn
Sep 30, 2025 4.13 Bn
Jun 30, 2025 2.78 Bn
Mar 31, 2025 3.98 Bn
Dec 31, 2024 2.06 Bn
Sep 30, 2024 4.27 Bn
Jun 30, 2024 3.88 Bn
Mar 31, 2024 -8.98 Bn
Dec 31, 2023 4.14 Bn
Sep 30, 2023 4.57 Bn
Jun 30, 2023 4.29 Bn
Mar 31, 2023 5.20 Bn
Dec 31, 2022 4.38 Bn
Sep 30, 2022 4.80 Bn
Jun 30, 2022 4.54 Bn
Mar 31, 2022 4.27 Bn
Dec 31, 2021 4.44 Bn
API Access

Bristol Myers Squibb EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda&ticker=BMY&period=max&api_key=YOUR_API_KEY